BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Monitors an issue for FDA in digital pathology imaging

Oct. 23, 2009
By Mark McCarty
GAITHERSBURG, Maryland – There is no novelty to the assertion that technology drives FDA's regulations, so the fact that FDA would convene a two-day session with the hematology and pathology devices advisory committee to discuss how to reliably employ digital images of pathology slides in diagnostic workups is not a surprise. (Medical Device Daily)
Read More

Washington roundup: Philips said to be clear of issues in warning letter

Oct. 22, 2009
By Mark McCarty

Washington roundup: Baxter snared by FDA warning for changes to manufacturing

Oct. 21, 2009
By Mark McCarty

Washington roundup: FDA reports inter-agency review of QoL for LASIK

Oct. 19, 2009
By Mark McCarty

Washington roundup: Sharfstein: FDA not up for 'old standards' in new er

Oct. 16, 2009
By Mark McCarty

Investors see diagnostics as reliable avenue for returns

Oct. 15, 2009
By Mark McCarty

FDAer: 510(k) 'not a rubber stamp or fast-track' process

Oct. 15, 2009
By Mark McCarty
WASHINGTON — The Advanced Medical Technology Association (AdvaMed; Washington) held a session at its annual meeting titled "Demystifying the 510(k) Process," but the mood at the meeting was that if there's anything cryptic about the process, it's not where the process currently stands; it's where the process is headed. (Medical Device Daily)
Read More

Internal communication still a danger zone in discovery

Oct. 14, 2009
By Mark McCarty

Ubl: $40B tax on industry would be 'devastating'

Oct. 14, 2009
By Mark McCarty
WASHINGTON – The Advanced Medical Technology Association (AdvaMed; Washington) made use of its bully pulpit yesterday in a session during which the association's president and board chairman warned that the $40 billion tax on the device industry as embodied in the bill by the Senate Finance constitutes "a really devastating proposal for a large share of our membership." (Medical Device Daily)
Read More

Washington roundup: Arjo's patient lifts back in detention for warning letter

Oct. 13, 2009
By Mark McCarty
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing